Literature DB >> 29628359

Gene expression-phenotype associations in adults with eosinophilic esophagitis.

Evan S Dellon1, Sara R Selitsky2, Robert M Genta3, Richard H Lash4, Joel S Parker2.   

Abstract

BACKGROUND: Gene expression patterns have not been extensively examined in the context of clinical features of eosinophilic esophagitis (EoE). AIMS: To assess whether gene expression is associated with clinically defined phenotypes in adults with EoE.
METHODS: This was an analysis of prospectively collected esophageal biopsies in newly diagnosed EoE patients. We determined differential gene expression with a 94 gene panel in relation to clinical features and phenotypes. These included: endoscopic findings of esophageal rings, stricture, narrowing, linear furrows, exudates, edema, and dilation; an allergic phenotype; an inflammatory phenotype, and a fibrostenotic phenotype.
RESULTS: In 89 EoE cases analyzed, patients with exudates on endoscopy had multiple differences in gene expression compared to patients without exudates, though patients with exudates also had higher eosinophil counts (172 vs 106eos/hpf; p=.01). Genes associated with esophageal narrowing included CCL26 (q-value=0.028), ALOX15 (q=0.011), GRK5 (q=0.029), CPA3 (q=0.012), and TRIM2 (q=0.0027). TRIM2 was also associated with the fibrostenotic phenotype (q=0.0051). No genes were associated with the inflammatory or atopic phenotypes, or with dilation.
CONCLUSIONS: Multiple genes are associated with exudates, possibly related to higher eosinophil counts. However, a number of genes, including those related to both inflammation and remodelling, are associated with esophageal narrowing. In particular, TRIM2 is associated with clinical fibrotic phenotypes.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biopsy; Endoscopy; Fibrostenosis; Inflammation; RNA

Mesh:

Substances:

Year:  2018        PMID: 29628359      PMCID: PMC6059985          DOI: 10.1016/j.dld.2018.03.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  46 in total

Review 1.  TRIM-NHL proteins in development and disease.

Authors:  Cristina Tocchini; Rafal Ciosk
Journal:  Semin Cell Dev Biol       Date:  2015-10-26       Impact factor: 7.727

2.  Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype.

Authors:  Thomas M Runge; Swathi Eluri; Cary C Cotton; Caitlin M Burk; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

3.  Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.

Authors:  Evan S Dellon; Spencer Rusin; Jessica H Gebhart; Shannon Covey; Leana L Higgins; RoseMary Beitia; Olga Speck; Kimberly Woodward; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2015-03-17       Impact factor: 10.864

4.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner.

Authors:  Alain M Schoepfer; Ekaterina Safroneeva; Christian Bussmann; Tanja Kuchen; Susanne Portmann; Hans-Uwe Simon; Alex Straumann
Journal:  Gastroenterology       Date:  2013-08-13       Impact factor: 22.682

Review 5.  Tissue remodeling in eosinophilic esophagitis.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart J Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

6.  A single biopsy is valid for genetic diagnosis of eosinophilic esophagitis regardless of tissue preservation or location in the esophagus.

Authors:  Evan S Dellon; Vivek Yellore; Matthew Andreatta; James Stover
Journal:  J Gastrointestin Liver Dis       Date:  2015-06       Impact factor: 2.008

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  Identification of a novel Bcl-2-interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance-induced neuroprotection.

Authors:  Simon Thompson; Andrea N Pearson; Michelle D Ashley; Veronica Jessick; Brona M Murphy; Philip Gafken; David C Henshall; Kate T Morris; Roger P Simon; Robert Meller
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

9.  GWAS identifies four novel eosinophilic esophagitis loci.

Authors:  Patrick M A Sleiman; Mei-Lun Wang; Antonella Cianferoni; Seema Aceves; Nirmala Gonsalves; Kari Nadeau; Albert J Bredenoord; Glenn T Furuta; Jonathan M Spergel; Hakon Hakonarson
Journal:  Nat Commun       Date:  2014-11-19       Impact factor: 14.919

10.  Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study.

Authors:  Manish B Singla; Mirna Chehade; Diana Brizuela; Corinne L Maydonovitch; Yen-Ju Chen; Mary Ellen Riffle; Sami R Achem; Fouad J Moawad
Journal:  Clin Transl Gastroenterol       Date:  2015-12-17       Impact factor: 4.488

View more
  5 in total

1.  Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.

Authors:  Tetsuo Shoda; Ting Wen; Julie M Caldwell; Netali Ben-Baruch Morgenstern; Garrett A Osswald; Mark Rochman; Lydia E Mack; Jennifer M Felton; J Pablo Abonia; Nicoleta C Arva; Dan Atkins; Peter A Bonis; Kelley E Capocelli; Margaret H Collins; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; John Leung; Paul A Menard-Katcher; Vincent A Mukkada; Philip E Putnam; Amanda K Rudman Spergel; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Seema S Aceves; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2021-10-21       Impact factor: 22.682

2.  Maternal atopy and offspring epigenome-wide methylation signature.

Authors:  Hanna Danielewicz; Artur Gurgul; Anna Dębińska; Grzegorz Myszczyszyn; Tomasz Szmatoła; Anna Myszkal; Igor Jasielczuk; Anna Drabik-Chamerska; Lidia Hirnle; Andrzej Boznański
Journal:  Epigenetics       Date:  2020-09-09       Impact factor: 4.528

3.  Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3.

Authors:  Premkumar Siddhuraj; Carl-Magnus Clausson; Caroline Sanden; Manar Alyamani; Mohammad Kadivar; Jan Marsal; Joanna Wallengren; Leif Bjermer; Jonas S Erjefält
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 4.  Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells.

Authors:  Dmitri Atiakshin; Andrey Kostin; Ivan Trotsenko; Vera Samoilova; Igor Buchwalow; Markus Tiemann
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

5.  Dynamically upregulated mast cell CPA3 patterns in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Premkumar Siddhuraj; Jimmie Jönsson; Manar Alyamani; Pavan Prabhala; Mattias Magnusson; Sandra Lindstedt; Jonas S Erjefält
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.